Press Releases :: Nighthawk Biosciences, Inc. (NHWK)

Jul 29, 2020 7:30am EDT

Heat Biologics COVID-19 Vaccine Demonstrates Immunogenicity Proof-of-Concept in Pre-Clinical Studies

Jul 27, 2020 6:30am EDT

Heat Biologics Regains Compliance with Nasdaq Minimum Bid Price Rule

Jun 22, 2020 7:30am EDT

Heat Biologics Announces First Patient Treated in First-in-Human Clinical Trial of PTX-35

Jun 18, 2020 7:30am EDT

Heat Biologics Announces Initiation of the Lead Clinical Trial Site for PTX-35

Jun 08, 2020 7:30am EDT

Heat Biologics Announces FDA Clearance of Investigational New Drug (IND) Application for PTX-35

Jun 04, 2020 7:30am EDT

Heat Biologics Provides Update on COVID-19 Vaccine Efforts

May 29, 2020 8:00am EDT

Heat Biologics Presents Positive Survival Benefit for HS-110 in Combination with Nivolumab in Phase 2 Lung Cancer Trial at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

May 27, 2020 8:00am EDT

Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine

May 15, 2020 9:30am EDT

Heat Biologics Provides First Quarter 2020 Business Update

May 14, 2020 8:00am EDT

Positive Survival Data from Phase 2 Lung Cancer Trial Accepted for Presentation at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

rss_feed News RSS

OUR ECOSYSTEM